HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stimulation of alpha7 nicotinic acetylcholine receptor by nicotine attenuates inflammatory response in macrophages and improves survival in experimental model of sepsis through heme oxygenase-1 induction.

Abstract
Activation of nicotinic acetylcholine receptor alpha7 subunit (α7nAChR) by nicotine leads to the improved survival rate in experimental model of sepsis. Previously, we demonstrated that heme oxygenase (HO)-1 inducers or carbon monoxide significantly increased survival of lipopolysaccharide (LPS)-induced and cecal ligation and puncture-induced septic mice by reduction of high mobility group box 1 release, a late mediator of sepsis. However, that activation of α7nAChR by nicotine provides anti-inflammatory action through HO-1 upregulation has not been elucidated. Here we show that HO-1-inducible effect by nicotine was mediated through sequential event-Ca(2+) influx, classical protein kinase C activation, and reactive oxygen species production-which activates phosphoinositol-3-kinase/Akt/Nrf-2 pathway. In addition, HO-1 is required for nicotine-mediated suppression of tumor necrosis factor-α, inducible nitric oxide synthase, and high mobility group box 1 expression induced by LPS in macrophages, as evidenced by the fact that nicotine failed to inhibit production of these mediators when HO-1 was suppressed. Importantly, nicotine-induced survival rate was reduced by inhibition of HO-1 in LPS- and cecal ligation and puncture-treated septic mice. Collectively, these data suggest that activation of α7nAChR by nicotine is critical in the regulation of anti-inflammatory process, which could be mediated through HO-1 expression. Thus, we conclude that activation of α7nAChR by nicotine provides anti-inflammatory action through HO-1 upregulation.
AuthorsKonstantin Tsoyi, Hwa Jin Jang, Jong Woo Kim, Hong Kyung Chang, Young Soo Lee, Hyun-Ock Pae, Hye Jung Kim, Han Geuk Seo, Jae Heun Lee, Hun-Taeg Chung, Ki Churl Chang
JournalAntioxidants & redox signaling (Antioxid Redox Signal) Vol. 14 Issue 11 Pg. 2057-70 (Jun 2011) ISSN: 1557-7716 [Electronic] United States
PMID21083424 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents
  • Chrna7 protein, human
  • Chrna7 protein, mouse
  • HMGB1 Protein
  • Lipopolysaccharides
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, mouse
  • Nicotinic Agonists
  • Reactive Oxygen Species
  • Receptors, Nicotinic
  • Tumor Necrosis Factor-alpha
  • alpha7 Nicotinic Acetylcholine Receptor
  • Nicotine
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Heme Oxygenase-1
  • NADPH Oxidases
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • Protein Kinase C
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Calcium Signaling (drug effects)
  • Cell Line
  • Endotoxemia (genetics, metabolism)
  • Gene Expression Regulation (drug effects)
  • HMGB1 Protein (metabolism)
  • Heme Oxygenase-1 (antagonists & inhibitors, genetics, metabolism)
  • Humans
  • Inflammation (chemically induced, prevention & control)
  • Kaplan-Meier Estimate
  • Lipopolysaccharides (toxicity)
  • Macrophages (drug effects, metabolism)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • NADPH Oxidases (metabolism)
  • NF-E2-Related Factor 2 (metabolism)
  • Nicotine (pharmacology)
  • Nicotinic Agonists (pharmacology)
  • Nitric Oxide Synthase Type II (metabolism)
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Protein Kinase C (metabolism)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Reactive Oxygen Species (metabolism)
  • Receptors, Nicotinic (metabolism)
  • Sepsis (genetics, metabolism)
  • Signal Transduction (drug effects)
  • Tumor Necrosis Factor-alpha (metabolism)
  • alpha7 Nicotinic Acetylcholine Receptor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: